esophageal cancer
Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test
Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device.
Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers
The partners will use mass spec to look at markers in Barrett's patients who either progressed to more severe disease states or remained stable over a 10-year period.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test
The firm presented initial study results from the test, which identifies six cancers, showing overall sensitivity at 86 percent and specificity of 95 percent.
Early Copy Number Changes Predict Progression of Barrett's Esophagus to Esophageal Cancer
The findings suggested that genomic surveillance of Barrett's esophagus could identify patients who will progress years in advance and enable earlier treatment.